Black Diamond Therapeutics (BDTX) Shares Outstanding (Entity) (2018 - 2026)
Black Diamond Therapeutics (BDTX) Shares Outstanding (Entity) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 62.54 Mn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 399.00 Mn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 113.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 133.73 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 252.88 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 218.28 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 575.47 Mn |
| 10 | Black Diamond Therapeutics | 126.49 Mn | 15.99 Mn | - | 57.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 57.45 Mn |
| Mar 31, 2026 | 57.30 Mn |
| Dec 31, 2025 | 57.14 Mn |
| Sep 30, 2025 | 56.94 Mn |
| Jun 30, 2025 | 56.89 Mn |
| Mar 31, 2025 | 56.68 Mn |
| Dec 31, 2024 | 56.64 Mn |
| Sep 30, 2024 | 56.52 Mn |
| Jun 30, 2024 | 56.41 Mn |
| Mar 31, 2024 | 52.53 Mn |
| Dec 31, 2023 | 51.65 Mn |
| Sep 30, 2023 | 51.64 Mn |
| Jun 30, 2023 | 36.53 Mn |
| Mar 31, 2023 | 36.51 Mn |
| Dec 31, 2022 | 36.43 Mn |
| Sep 30, 2022 | 36.37 Mn |
| Jun 30, 2022 | 36.32 Mn |
| Mar 31, 2022 | 36.29 Mn |
| Dec 31, 2021 | 36.23 Mn |
| Sep 30, 2021 | 36.23 Mn |